Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033189
Status:
COMPLETED
Last Update Posted:
2010-11-16
First Post:
2002-04-08
Brief Title:
An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy
Sponsor:
Cooperative International Neuromuscular Research Group
Organization:
Cooperative International Neuromuscular Research Group
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2010-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will help to determine the safety and efficacy of the nutritional supplement Coenzyme Q10 when added to steroids as a treatment for Duchenne muscular dystrophy DMD Boys with DMD who are enrolled in this study will should be on a stable dose of steroids for at least six months and will remain on their usual dose throughout the study They will complete two screening visits within a one-week period and if enrolled will then have their strength tested monthly for three months before beginning therapy with Coenzyme Q10 Once Coenzyme Q10 therapy is started participants will have their strength tested monthly for six months Following the six month treatment period participants will be given the option to remain on Coenzyme Q10 until the study is completed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None